sank in late trading Thursday after the video-game publisher reported a wider-than-expected second-quarter loss amid rising product costs and a huge write-off.
For the quarter ended April 30, Take-Two posted a loss of $50.4 million, or 71 cents a share, widened from $8.2 million, or 12 cents a share, a year ago. The bottom line included a charge of 24 cents a share related to restructuring. Without that charge, the company still would have recorded a loss of about 47 cents a share. Analysts polled by Thomson First Call had predicted the company would post a loss of 11 cents a share before the charge. The wider loss came even as sales jumped 19% to $265.1 million, topping Wall Street's estimate of $258.8 million. Take-Two shares dropped $2.27, or 13%, to $14.50 in after-hours trading.
surged after the health care information-systems company beat Wall Street's fourth-quarter earnings estimates. The company posted earnings of $7.6 million, or 28 cents a share, for the quarter ended March 31, topping analysts' average forecast of 23 cents. A year earlier, the company earned $4.8 million, or 18 cents a share. Revenue climbed 39% to $35.6 million, compared with Wall Street's target of $33.2 million. Shares jumped $3.15, or 10%, to $35.15 in late trading.
shares rose after the outdoor-sporting-goods company matched Wall Street's second-quarter earnings expectation. For the quarter ended April 30, the company reported earnings of $3.7 million, or 3 cents a share, down from $34.7 million, or 28 cents a share a year ago. The company's results included the Rossignol and Cleveland Gold businesses, which were acquired in July 2005. Rossignol's business is seasonal, and hurt the company's second-quarter results, Quiksilver said. Revenue increased to $516.9 million from $426.9 million. Wall Street was looking for earnings of 3 cents a share on revenue of $527.3 million.
Quiksilver reiterated its forecast for fiscal 2006 revenue of $2.25 billion to $2.27 billion and earnings of 87 cents to 88 cents a share, before about 11 cents in stock-options costs. Analysts anticipate earnings of 76 cents a share on revenue of $2.27 billion. Shares gained 60 cents, or 5%, to $12.60 after hours.
slipped after the Las Vegas-based company swung to a second-quarter loss, hurt by a writedown at its Stargames unit. The gaming-equipment maker reported a loss of $12.7 million, or 37 cents a share, reversing a year-ago profit of $6.8 million, or 19 cents a share. The latest quarter included a 55-cent writedown on the Stargames buy and a 3-cent loss from Stargames' operations. Excluding those costs, the profit was 21 cents a share, a penny shy of Wall Street's estimate. Revenue rose to $43.3 million from $27.1 million a year earlier, beating analysts' target of $38 million.
Shuffle Master predicted full-year earnings of $1.02 to $1.05 a share for the year, excluding Stargames charges and stock costs. Analysts are looking for earnings of 96 cents a share. The stock fell $2.21, 6%, to $34.55 after hours.
stumbled after the Phoenix-based health care products company posted a wider fiscal third-quarter loss and said it might realign its business. For the quarter ended April 30, the company's loss swelled to $8.1 million, or 18 cents a share, from $2.2 million, or 5 cents a share, a year ago. Revenue dropped 44% to $6.8 million.
Zila said it is exploring the sale of its nutraceuticals division to focus on its cancer-detection business. "We have received several competitive offers as part of this process," the company said. "We are currently negotiating with one party. It is our intent to either close a transaction with that party or continue our negotiations with other interested bidders to determine whether we are able to close a transaction under acceptable terms." For the third quarter, Zila Nutraceuticals recorded revenue of $3.6 million, down 65% from a year earlier. Zila shares dropped 25 cents, or 7.2%, to $3.23 in late trading.